Ildong Pharmaceutical advances into the Chinese market for raw materials for hypertension treatment

COMPANY / Reporter Kim Jisun / 2023-08-23 01:46:30
 

 

[Alpha Biz=(Chicago) Reporter Kim Jisun] Ildong Pharmaceutical Co. said on the 22nd that it has decided to export its cardiovascular raw material drug (API) Benidine Hydrochloride’ to Guangzhou Tosun Pharmaceutical in Guangzhou, China.

Benidipine is a calcium channel blocker (CCB) that expands blood vessels and relieves the burden on the heart by blocking the passage of calcium ions involved in the contraction of blood vessels and heart muscles, and is mainly used to treat high blood pressure and angina.

The company said it has recently signed a contract on a partnership between the two companies, including Tosun and Benidipine supply, and is carrying out all the necessary procedures to advance into China. Ildong Pharmaceutical had previously obtained registration and approval of raw materials for Benidipine from Chinese drug management authorities.

 

Alphabiz Reporter Kim Jisun(stockmk2020@alphabiz.co.kr)

어플

주요기사

Lotte Chilsung to Offer First-Ever Voluntary Retirement Program in 75 Years
Police Refer Former Doosan Bobcat Korea Executives to Prosecutors Over Bid-Rigging and Bribery Allegations
SK Group to Launch Early Year-End Executive Reshuffle; Major Layoffs Expected at SK Telecom
KT Accused of Concealing 2024 Malware Infection Affecting Subscriber Data; Government Probe Finds Security Failures Behind Micropayment Hacking
Korea’s National Pension Service Gains Strong Q3 Returns from U.S. Tech Stocks Amid Market Rally
뉴스댓글 >

SNS